organ transplant Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection Under the policy, covered tests must provide information about active rejection status or cellular or antibody-mediated rejection status. CareDx Acquires European Transplant Surveillance Software Firm BFS Molecular The company uses next-generation sequencing data to track the health of transplanted organs and stem cells over time. CareDx Expanding Diagnostic Tech Into Cell Transplant Monitoring Premium The company is also continuing to expand its digital technology offering to help clinicians track their patients' health more easily. CareDx Q4 Revenues Up 64 Percent The company reported $58.6 million in total revenues for the quarter and said testing services revenues rose 73 percent year over year. Roche Receives FDA Clearance for Cobas BKV Test for Use With Urine Samples The test was previously cleared by the FDA for use with ethylenediaminetetraacetic acid plasma samples to manage BK virus in transplant patients. Feb 8, 2021 Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test Jan 27, 2021 Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy Premium Jan 21, 2021 CareDx Prices $175M Common Stock Offering Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Jan 11, 2021 CareDx Preliminary Q4 Revenues Up 63 Percent, Beat Estimates Jan 7, 2021 CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Nov 6, 2020 Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests Premium Nov 5, 2020 Natera Q3 Revenues Up 26 Percent on Increased Testing Volumes Nov 3, 2020 Natera Aims to Improve Prospera Kidney Test After Findings Reveal Cell-Free DNA Changes in Infection Premium Oct 29, 2020 CareDx Q3 Revenues Up 58 Percent Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 7, 2020 CareDx Preliminary Q3 Revenues Up 57 Percent Oct 1, 2020 CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto Aug 5, 2020 Natera Revenues Climb 16 Percent in Q2 Driven by Reproductive Health Business Aug 5, 2020 NeuMoDx Molecular Receives CE Mark for Quantitative BK Viral Assay Aug 4, 2020 CareDx Q2 Revenues Up 33 Percent Jun 26, 2020 BTIG Initiates Coverage of CareDx With Buy Rating Jun 11, 2020 CareDx Prices $125M Public Stock Offering May 15, 2020 CareDx Hybrid Capture Tech for HLA Testing Receives CE Marking Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.